GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors.

by Atsuko Fukazawa, Carmen Alonso, Kiyotaka Kurachi, Sonal Gupta, Cammie F Lesser, Beth Ann McCormick, Hans-Christian Reinecker
Published 2008-11-01

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)

by Yoichiro Yoshida, Takeshi Yamada, Hiroshi Matsuoka, Hiromichi Sonoda, Atsuko Fukazawa, Hiroshi Yoshida, Hideyuki Ishida, Keiji Hirata, Suguru Hasegawa, Kazuhiro Sakamoto, Toshiaki Otsuka, Keiji Koda
Published 2019-07-01

Geospatial Assessments of DNA Adducts in the Human Stomach: A Model of Field Cancerization

by Yuji Iwashita, Ippei Ohnishi, Yuto Matsushita, Shunsuke Ohtsuka, Takashi Yamashita, Keisuke Inaba, Atsuko Fukazawa, Hideto Ochiai, Keigo Matsumoto, Nobuhito Kurono, Yoshitaka Matsushima, Hiroki Mori, Shioto Suzuki, Shohachi Suzuki, Fumihiko Tanioka, Haruhiko Sugimura
Published 2021-07-01

Mass spectrometric profiling of DNA adducts in the human stomach associated with damage from environmental factors

by Ippei Ohnishi, Yuji Iwashita, Yuto Matsushita, Shunsuke Ohtsuka, Takashi Yamashita, Keisuke Inaba, Atsuko Fukazawa, Hideto Ochiai, Keigo Matsumoto, Nobuhito Kurono, Yoshitaka Matsushima, Hiroki Mori, Shioto Suzuki, Shohachi Suzuki, Fumihiko Tanioka, Haruhiko Sugimura
Published 2021-04-01